Valeo Pharma Inc (VPH.TO)
0.105
-0.01
(-8.70%)
CAD |
TSX |
May 03, 16:00
Valeo Pharma Cash from Operations (TTM): -2.972M for Jan. 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -2.972M |
October 31, 2023 | -15.70M |
July 31, 2023 | -24.14M |
April 30, 2023 | -25.02M |
January 31, 2023 | -30.54M |
October 31, 2022 | -28.50M |
July 31, 2022 | -19.92M |
April 30, 2022 | -23.27M |
January 31, 2022 | -18.67M |
October 31, 2021 | -12.32M |
July 31, 2021 | -11.71M |
Date | Value |
---|---|
April 30, 2021 | -7.045M |
January 31, 2021 | -6.438M |
October 31, 2020 | -5.298M |
July 31, 2020 | -3.553M |
April 30, 2020 | -4.029M |
January 31, 2020 | -3.651M |
October 31, 2019 | -2.307M |
July 31, 2019 | -2.488M |
April 30, 2019 | -1.732M |
January 31, 2019 | -1.125M |
October 31, 2018 | -1.351M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-30.54M
Minimum
Jan 2023
-2.307M
Maximum
Oct 2019
-13.03M
Average
-11.71M
Median
Jul 2021
Cash from Operations (TTM) Benchmarks
Biocure Technology Inc | -0.4423M |
Core One Labs Inc | -- |
Nova Mentis Life Science Corp | -- |
Nanosphere Health Sciences Inc | -0.0378M |
Lobe Sciences Ltd | -2.279M |